Breast implant illness (BII), also known as autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA), along with other terms, is a purported condition that is said to affect certain women with breast implants. Its acceptance as a legitimate disease is controversial,[2][3] but some evidence exists supporting the idea that silicone-based breast implants can trigger autoimmune responses in patients with underlying allergies or autoimmune diseases.[1] Nonetheless, it remains poorly defined, and its existence has still not been conclusively proven.[3][4] The idea of BII has existed since the 1960s,[2] but it has more recently been popularized on social media — particularly among non-experts — a process that may increase fear and anxiety regarding the condition and encourage self-diagnosis.[4]
^ abYang, Siling; Klietz, Marie-Luise; Harren, Anna Katharina; Wei, Qiang; Hirsch, Tobias; Aitzetmüller, Matthias M (15 March 2022). "Understanding Breast Implant Illness: Etiology is the Key". Aesthetic Surgery Journal. 42 (4): 370–377. doi:10.1093/asj/sjab197.